Establishment Labs Submits Module Four to U.S. FDA for Premarket Approval of Motiva and Reports Record Fourth Quarter and Full Year 2022 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. HOOD
10. IBM

Go back to Establishment Labs Submits Module Four to U.S. FDA for Premarket Approval of Motiva and Reports Record Fourth Quarter and Full Year 2022 Financial Results

Establishment Labs Holdings (ESTA) Tops Q4 EPS by 13c

February 27, 2023 4:03 PM EST

Establishment Labs Holdings (NASDAQ: ESTA) reported Q4 EPS of ($0.55), $0.13 better than the analyst estimate of ($0.68). Revenue for the quarter came in at $43.8 million versus the consensus estimate of $43.28 million.

For earnings history and earnings-related data on Establishment Labs Holdings (ESTA) click here.

... More